NCT03832803

Brief Summary

Radical radiotherapy to the prostate is conventionally treated with a full bladder with the aim of minimising dose to the bladder and small bowel to prevent significant side effects. Tolerance of the bladder filling protocol varies depending on patients' baseline urinary function. It is not uncommon for some men to have "accidents" during treatment causing understandable distress. This can also extend the treatment time and cause knock on delays in the radiotherapy department. Several United Kingdom (UK) centres report treating with an empty bladder. The investigators carried out a feasibility study comparing treatment with full bladder to empty bladder to ascertain if the investigators can safely change our protocol to that of an empty bladder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable prostate-cancer

Timeline
Completed

Started Mar 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2019

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

January 29, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
Last Updated

February 6, 2019

Status Verified

February 1, 2019

Enrollment Period

1 year

First QC Date

January 29, 2019

Last Update Submit

February 5, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in IPSS score

    IPSS - The International Prostate Symptom Score is a 7 question scale which assesses urinary toxicity. Each question is scored 0-5 totalling a maximum score of 35. A score of 0-7 correlates to mildly symptomatic; 8-19, moderately symptomatic; 20-35, severely symptomatic.

    Baseline to end of treatment (4 weeks or 7 and a half weeks depending on radiotherapy schedule); to 6 week follow up; and to 1 year follow up.

Secondary Outcomes (2)

  • Change in LENT SOMA score

    Baseline to end of treatment (4 weeks or 7 and a half weeks depending on radiotherapy schedule); to 6 week follow up; and to 1 year follow up.

  • Bowel and bladder DVH

    At time of radiotherapy planning scan which happens at baseline, on day of randomisation.

Study Arms (2)

Empty Bladder

EXPERIMENTAL

Empty bladder prior to treatment.

Behavioral: Empty bladder

Full Bladder

OTHER

Conventional drinking protocol - 200ml water prior to treatment.

Behavioral: Full bladder

Interventions

Empty bladderBEHAVIORAL

No drinking protocol.

Empty Bladder
Full bladderBEHAVIORAL

Followed drinking protocol

Full Bladder

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Prostate cancer receiving radical radiotherapy.

You may not qualify if:

  • Not nodal disease.
  • Not prostate bed radiotherapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lancashire Teaching Hospitals NHS Foundation Trust

Preston, United Kingdom

Location

MeSH Terms

Conditions

Prostatic NeoplasmsRadiation Injuries

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesWounds and Injuries

Study Officials

  • Alison Birtle

    Lancashire Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Investigator masking for randomisation purposes only. Masking not possible for intervention whilst on treatment.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 50 patients receiving radical radiotherapy to the prostate were randomised using 1:1 into 2 groups. Group A followed the conventional drinking protocol at our centre (200ml prior to treatment) and group B were treated with an empty bladder. Baseline, end of treatment and 6 week follow up scores were prospectively collected for IPSS, LENT SOMA bowel toxicity and quality of life questionnaires.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 29, 2019

First Posted

February 6, 2019

Study Start

March 1, 2017

Primary Completion

March 1, 2018

Study Completion

January 25, 2019

Last Updated

February 6, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Locations